Clinical trial

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

NCT00380770

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Generic HAART Triomune : d4T, 3TC, NVP Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABV Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2003-01-01

PhasePHASE4

Conditions

HIVunresolved

AIDSverified · MONDO: AIDS

Kaposi's Sarcomaverified · MONDO: Kaposi's sarcoma

Human Herpesvirus 8unresolved

Interventions

Generic HAART Triomune : d4T, 3TC, NVPDRUG

Generic HAART Triomune : d4T, 3TC, NVP and chemotherapy ABVDRUG

Sponsors & collaborators

University of KwaZululead sponsor

AIDS Care Research in Africacollaborator

National Research Foundation, Singaporecollaborator

AIDS Malignancy Consortiumcollaborator

Cipla Medprocollaborator

Dermatological Society of South Africacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00380770 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.